# EDGAR Filing Document

**Accession Number:** 0000888981
**File Stem:** 0001553350-26-000086
**Filing Date:** 2026-5
**Character Count:** 74812
**Document Hash:** 7f6e9d0b24d5ffccd4154e8df8a31c8a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001553350-26-000086.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001553350-26-000086

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 56

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NOCOPI TECHNOLOGIES INC/MD/
- **CENTRAL INDEX KEY:** 0000888981
- **STANDARD INDUSTRIAL CLASSIFICATION:** GAMES, TOYS & CHILDREN'S VEHICLES (NO DOLLS & BICYCLES) [3944]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 870406496
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-20333
- **FILM NUMBER:** 26987770

**BUSINESS ADDRESS:**
- **STREET 1:** 480 SHOEMAKER ROAD
- **STREET 2:** SUITE 104
- **CITY:** KING OF PRUSSIA
- **STATE:** PA
- **ZIP:** 19406
- **BUSINESS PHONE:** 6108349600

**MAIL ADDRESS:**
- **STREET 1:** 480 SHOEMAKER ROAD
- **STREET 2:** SUITE 104
- **CITY:** KING OF PRUSSIA
- **STATE:** PA
- **ZIP:** 19406

?xml version='1.0' encoding='ASCII'? 10-Q

**United States**

**Securities and Exchange Commission**

**Washington, D.C. 20549**

**Form 10-Q**

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2026

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from _________________ to ______________

Commission File Number: 000-20333

**NOCOPI TECHNOLOGIES, INC.**

*(Exact name of registrant as specified in its charter)*

---

| | |
|:---|:---|
| **Maryland** | **87-0406496** |
| *(State or other jurisdiction of incorporation or organization)* | *(I.R.S. Employer Identification No.)* |

---

**480 Shoemaker Road, Suite 104, King of Prussia, PA 19406**

*(Address of principal executive offices) (Zip Code)*

**(610) 834-9600**

*(Registrant's telephone number, including area code)*

Securities registered pursuant to Section 12(b) of the Act: None.

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer&nbsp;&nbsp;&nbsp;&nbsp; ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 11,101,789 shares of common stock, par value $0.01, as of May 12, 2026.

**<u>NOCOPI TECHNOLOGIES, INC.</u>**

**INDEX**

---

| | |
|:---|:---|
|  | **PAGE** |
| **Part I. FINANCIAL INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 1. [Financial Statements](#a_001) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Statements of Comprehensive (Loss) Income for the Three Months Ended March 31, 2026 and March 31, 2025](#a_002) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Balance Sheets at March 31, 2026 and December 31, 2025](#a_003) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Statements of Cash Flows for the Three Months Ended March 31, 2026 and March 31, 2025](#a_004) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Statements of Stockholders' Equity for the Three Months Ended March 31, 2026 and March 31, 2025](#a_005) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Notes to the Condensed Financial Statements](#a_006) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 2. [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_007) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 3. [Quantitative and Qualitative Disclosures About Market Risk](#a_008) | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 4. [Controls and Procedures](#a_010) | 16 |
| **Part II. OTHER INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 1. [Legal Proceedings](#a_010) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 1A. [Risk Factors](#a_011) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 2. [Unregistered Sales of Equity Securities and Use of Proceeds.](#a_012) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 3. [Defaults Upon Senior Securities](#a_013) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 4. [Mine Safety Disclosures](#a_014) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 5. [Other Information](#a_015) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 6. [Exhibits](#a_016) | 17 |
| **[SIGNATURES](#a_017)** | 18 |

---

i

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

***Nocopi Technologies, Inc.***

***Condensed Statements of Comprehensive (Loss) Income\****

***(unaudited)***

---

| | | |
|:---|:---|:---|
|  | **Three Months ended** <br> **March 31** | **Three Months ended** <br> **March 31** |
|  | **2026** | **2025** |
| **Revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Licenses, royalties and fees | $100700 | $190300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product and other sales | 289000 | 288700 |
| Total revenues | 389700 | 479000 |
| **Cost of revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Licenses, royalties and fees | 46400 | 43500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product and other sales | 152700 | 161800 |
| Total cost of revenues | 199100 | 205300 |
| **Gross profit** | 190600 | 273700 |
| **Operating expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 55800 | 45000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 74500 | 91000 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 221800 | 223500 |
| Total operating expenses | 352100 | 359500 |
| **Net loss from operations** | (161500) | (85800) |
| **Other income (expenses)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 105200 | 117200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and bank charges | (6000) | (5900) |
| Total other income | 99200 | 111300 |
| **Net (loss) income before income taxes** | (62300) | 25500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes |  |  |
| **Net (loss) income** | $(62300) | $25500 |
| **Net (loss) income per common share** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic and Diluted | $(.006) | $.002 |
| **Weighted average common shares outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic and Diluted | 11057345 | 10792913 |

---

\*See accompanying notes to these condensed financial statements.

***Nocopi Technologies, Inc.***

***Condensed Balance Sheets\****

***(unaudited)***

---

| | | |
|:---|:---|:---|
|  | **March 31**<br>**2026** | **December 31**<br>**2025** |
| **Assets** |  |  |
| **Current assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cash and cash equivalents | $11913000 | $11553600 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable less $12,000 allowance for credit losses | 1132000 | 936700 |
| &nbsp;&nbsp;&nbsp;&nbsp; Inventory, net of allowance of $94,100 and $114,200, respectively | 404100 | 456900 |
| &nbsp;&nbsp;&nbsp;&nbsp; Prepaid and other | 86800 | 144100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current assets | 13535900 | 13091300 |
| Fixed assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Leasehold improvements | 95100 | 81500 |
| &nbsp;&nbsp;&nbsp;&nbsp; Furniture, fixtures and equipment | 179700 | 179700 |
| &nbsp;&nbsp;&nbsp;&nbsp; Fixed assets, gross | 274800 | 261200 |
| &nbsp;&nbsp;&nbsp;&nbsp; Less: accumulated depreciation and amortization | 253600 | 251200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total fixed assets | 21200 | 10000 |
| Other assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Long-term receivables | 639600 | 775000 |
| &nbsp;&nbsp;&nbsp;&nbsp; Operating lease right of use – building | 142300 | 161300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other assets | 781900 | 936300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $14339000 | $14037600 |
| **Liabilities and Stockholders' Equity** |  |  |
| **Current liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts payable | $33500 | $30600 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses | 114200 | 153300 |
| &nbsp;&nbsp;&nbsp;&nbsp; Stock compensation payable | 48300 | 26700 |
| &nbsp;&nbsp;&nbsp;&nbsp; Operating lease liability – current | 82200 | 80200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities | 278200 | 290800 |
| **Long-term liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Operating lease liability – non-current | 67100 | 88700 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses, non-current | 44700 | 54300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total long-term liabilities | 111800 | 143000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 390000 | 433800 |
| **Stockholders' equity** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $1.00 par value, authorized – 3,000,000 shares |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.01 par value, authorized – 75,000,000 shares, <br>Issued and outstanding – March 31, 2026-11,101,789 shares; <br>December 31, 2025-10,835,123 | 111000 | 108300 |
| &nbsp;&nbsp;&nbsp;Paid-in capital | 26103700 | 25698900 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (12265700) | (12203400) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 13949000 | 13603800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $14339000 | $14037600 |

---

\*See accompanying notes to these condensed financial statements.

***Nocopi Technologies, Inc.***

***Condensed Statements of Cash Flows\****

***(unaudited)***

---

| | | |
|:---|:---|:---|
|  | **Three Months ended** <br> **March 31** | **Three Months ended** <br> **March 31** |
|  | **2026** | **2025** |
| **Operating Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Net (loss) income | $(62300) | $25500 |
| &nbsp;&nbsp;&nbsp;&nbsp; Adjustments to reconcile net (loss) income to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and amortization | 2400 | 1700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stock-based compensation | 29100 | 23600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of operating lease right of use-building | 19000 | 19300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory reserve | (20100) | (4400) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable | (195300) | 55200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory | 72900 | 30200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid and other current assets | 57300 | 61600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long-term receivables | 135400 | 96000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts payable | 2900 | 42000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses | (48700) | 40000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liability-current | (19600) | (21000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash (used in) provided by operating activities | (27000) | 369700 |
| **Investing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of fixed assets | (13600) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used in investing activities | (13600) |  |
| **Financing Activities** |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp; Issuance of common stock** | 400000 |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by financing activities** | 400000 |  |
| **Increase in cash and cash equivalents** | 359400 | 369700 |
| **Cash and Cash Equivalents** |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp; Beginning of period** | 11553600 | 10839700 |
| &nbsp;&nbsp;&nbsp;&nbsp; End of period | $11913000 | $11209400 |

---

\*See accompanying notes to these condensed financial statements.

***Nocopi Technologies, Inc.***

***Condensed Statements of Stockholders' Equity\****

***For the Three Months ended March 31, 2026 and March 31, 2025***

(***unaudited***)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** | | | |
|  | **Shares** | **Amount** | **Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** |<br>**Total** |
| **Balance at December 31, 2025** | 10835123 | $108300 | $25698900 | $(12203400) | $13603800 |
| Stock-based compensation |  |  | 7500 |  | 7500 |
| Issuance of common stock | 266666 | 2700 | 397300 |  | 400000 |
| Net loss |  |  |  | (62300) | (62300) |
| **Balance at March 31, 2026** | 11101789 | $111000 | $26103700 | $(12265700) | $13949000 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** | | | |
|  | **Shares** | **Amount** | **Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** |<br>**Total** |
| **Balance at December 31, 2024** | 10792913 | $107900 | $25580400 | $(12048500) | $13639800 |
| Stock-based compensation |  |  | 2000 |  | 2000 |
| Net income |  |  |  | 25500 | 25500 |
| **Balance at March 31, 2025** | 10792913 | $107900 | $25582400 | $(12023000) | $13667300 |

---

\* See accompanying notes to these condensed financial statements.

 **<u>NOCOPI TECHNOLOGIES, INC.</u>**

**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**Note 1. Financial Statements**

The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (the "Company"). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in Note 2. Significant Accounting Policies included in the Notes to Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 31, 2026 (the "2025 Annual Report"). Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The notes to financial statements included in the 2025 Annual Report should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three months ended March 31, 2026 may not be necessarily indicative of the operating results expected for the full year.

The Company follows Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 220 in reporting comprehensive (loss) income. Comprehensive (loss) income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net (loss) income. Since the Company has no items of other comprehensive (loss) income, comprehensive (loss) income is equal to net (loss) income.

**Recently Issued Accounting Pronouncements Not Yet Adopted**

In November 2024, the FASB issued ASU No. 2024-03, *Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses* (ASU 2024-03). The new guidance requires disaggregated information about certain income statement expense line items on an annual and interim basis. This guidance will be effective for annual periods beginning the year ended December 31, 2027 and for interim periods thereafter. The new standard permits early adoption and can be applied prospectively or retrospectively. We are evaluating the effect that this guidance will have on our consolidated financial statements and related disclosures.

**Note 2**. **Cash and Cash Equivalents**

---

| | | |
|:---|:---|:---|
|  | **March 31**<br> **2026** | **December 31**<br> **2025** |
| Cash and cash equivalents |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cash and money market funds | $11913000 | $11553600 |
| &nbsp;&nbsp;&nbsp;&nbsp; Cash and cash equivalents | $11913000 | $11553600 |

---

The Company currently maintains, and may in the future maintain, assets at certain financial institutions in the United States in amounts that are, and in the future may be, in excess of the Federal Deposit Insurance Corporation ("FDIC") insurance limit of $250,000. At March 31, 2026 and December 31, 2025, the Company had $11,663,000 and $11,303,600 in excess of the FDIC insured limit, respectively. In the event of a failure of any financial institutions where the Company maintains deposits or other assets, the Company may incur a loss to the extent such loss exceeds the FDIC insurance limitation, which could have a material adverse effect on liquidity, financial condition and results of operations. Interest income earned was $98,000 and $112,300 for the three months ended March 31, 2026 and 2025, respectively, included in interest income on the condensed statement of comprehensive loss.

**Note 3. Inventories**

---

| | | |
|:---|:---|:---|
|  | **March 31<br> 2026** | **December 31<br> 2025** |
| Inventories consist of the following |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Raw materials | $470400 | $571100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Work in process | 19400 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Finished goods | 8400 |  |
| **Inventory gross** | 498200 | 571100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Allowance | (94100) | (114200) |
| **Inventory** | $404100 | $456900 |

---

<br> **<u>NOCOPI TECHNOLOGIES, INC.</u>**<br>**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**<br>**(UNAUDITED)**<br>

**Note 4. Long-term Receivables**

As of March 31, 2026 and December 31, 2025, the Company had long-term receivables of $639,600 and $775,000, respectively, from four licensees, respectively, representing the present value of fixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the second quarter of 2028. The fixed guaranteed royalty payments result from amendments to license agreements with three existing licensees and a license agreement with a new licensee. The receivable represents the present value of the fixed minimum annual payments due under the license agreements, discounted at the Company's incremental borrowing rate of 6.32% for two licensees that renewed in 2022 and 8.14% for a licensee that renewed in January 2025 and 5.52% for a new licensee in June 2025.

These agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a performance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of the licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The royalty payment is fixed or determinable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Collection of the royalty payment is considered probable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The licensee has the ability to benefit from the licensed technology

The Company determined that the above conditions were met upon execution of the four license agreements. The present value of the fixed guaranteed costs of obtaining the license agreements (sales commissions) was recorded upon renewal of three existing license agreements and a new license agreement with a new licensee. The sales commissions are amortized on a systematic basis consistent with the pattern of revenue recognition for the underlying these license agreements. The unamortized balance as of March 31, 2026 and December 31, 2025, for accrued commission payable was $85,600 and $96,100, respectively, included on the balance sheet in accrued expenses and accrued expenses, non-current.

The current portion of the license agreements in the amount of $584,100 and $599,400, is included in accounts receivable on the balance sheets as of March 31, 2026 and December 31, 2025, respectively.

The following table summarizes the future minimum payments due under the remaining three license agreements as of March 31, 2026:

---

| | |
|:---|:---|
| Year Ending December 31: |  |
| 2026 | $475500 |
| 2027 | 567500 |
| 2028 | 270000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1313000 |

---

The Company has evaluated the collectability of the long-term receivables and concluded that expected credit losses related to the receivables remain immaterial as of March 31, 2026. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees' financial condition or other factors.

The long-term receivables are recorded at its present value as of March 31, 2026, and the receivable and imputed interest will be amortized over the term of the license agreements using the effective interest method. The book value approximates the fair value for long-tern receivables. The unamortized balance of the long-term receivables as of March 31, 2026 and December 31, 2025 was $639,600 and $775,000, respectively. The unamortized imputed interest balance as of March 31, 2026 and December 31, 2025 was $83,000 and $90,200, respectively, which will be recognized as interest income through June 30, 2028. Interest income derived from long-term receivables was $7,200 and $4,900 for the three months ended March 31, 2026 and 2025, respectively, included in the statements of comprehensive (loss) income.

<br> **<u>NOCOPI TECHNOLOGIES, INC.</u>**<br>**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**<br>**(UNAUDITED)**<br>

**Note 5. Stockholders' Equity**

The Company follows FASB ASC 718, *Compensation – Stock Compensation*, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. On June 17, 2024, the Company's shareholders approved the Nocopi Technologies, Inc. 2024 Incentive Compensation Plan (the "2024 Plan"), which allows the Company to issue equity awards to directors, officers, other employees and consultants of the Company. As of March 31, 2026 and 2025, 41,930 and 5,000 unvested restricted stock units ("RSUs") are outstanding under the 2024 Plan, respectively. In addition, as of March 31, 2026 and 2025, 333,945 and 291,735 shares have been issued in settlement of vested RSUs granted under the 2024 Plan, respectively. As of March 31, 2026 and 2025, the unamortized value related to grants under the 2024 Plan was $61,800 and $6,100, respectively.

**Advisory Shares – Private Placement**

On September 11, 2023, the Company entered into a stock purchase agreement in connection with a private placement for total gross proceeds of $5.0 million. The agreement provided for the issuance of 1,250,000 shares of common stock at $4.00 per share. The sale closed on September 11, 2023. No placement fees or commissions were paid.

In addition, as consideration for advisory services through September 11, 2026, the Company agreed to issue 65,790 shares of common stock with a total grant-date fair value of $263,160, which vest in three equal tranches on September 11, 2024, 2025, and 2026.

The Company recognizes compensation expense for advisory share grants based on grant-date fair value and recognizes expense on a straight-line basis over the service period.

For the three months ended March 31, 2026 and 2025, the Company recognized consulting expense of $21,600 and $21,600, respectively, related to this stock grant.

On September 11, 2024 and September 11, 2025, the Company issued 21,930 shares of common stock at a fair value of $87,700 upon the vesting of the first and second tranches. As of March 31, 2026, unrecognized compensation expense related to the advisory shares was approximately $39,400, which will be recognized over the remaining service period.

**Director and Executive Grants**

On December 29, 2025, executives were granted 40,000 RSUs, of which 20,000 vested and 17,640 shares were issued immediately at a value of $26,500, net of taxes. The remaining 20,000 vest on December 29, 2026. The aggregate grant-date fair value was $60,000, of which $30,000 was recognized in 2025. The remaining amount will be recognized over the remaining vesting period.

**Private Placement**

On December 31, 2025, the Company entered into Stock Purchase Agreements (the "Purchase Agreements"), by and between the Company and various institutional investors (the "Purchasers").The Purchase Agreements provided for the private issuance (the "Private Placement") to the Purchasers of an aggregate of 266,666 shares of the Company's common stock (such shares of common stock issued pursuant to the Private Placement, the "Placement Shares") at a purchase price of $1.50 per share. On January 9, 2026, the Private Placement closed and the Company received aggregate gross proceeds of $400,000. No placement fees or commissions were paid in connection with this transaction.

Kevin Westenburg, the Company's President and a Director, purchased 33,333 Placement Shares in connection with the Private Placement.

Third Parties purchased an aggregate of 233,333 Placement Shares in connection with the Private Placement.

In connection with the Purchase Agreements, on December 31, 2025, the Company entered into registration rights agreements with certain of the Purchasers, which provides that on or prior to January 9, 2027, the Company must file a registration statement to register the Purchaser's respective Placement Shares.

<br> **<u>NOCOPI TECHNOLOGIES, INC.</u>**<br>**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**<br>**(UNAUDITED)**<br>

**Stock-Based Compensation Expense**

For the three months ended March 31, 2026 and 2025, the Company recognized stock-based compensation expense of $29,000 and $23,700, respectively.

As of March 31, 2026, total unrecognized compensation expense related to nonvested awards was approximately $61,800, which is expected to be recognized over a weighted-average period of approximately one year.

**Note 6. Income Taxes**

There was no income tax expense reflected in the results of operations for the quarter ended March 31, 2026 [and 2025] and the year ended December 31, 2025, due to the recording of a full valuation allowance since it is more likely than not that that the realization of the net deferred tax assets would not be realized. The valuation allowance at March 31, 2026 and December 31, 2025 were $565,600 and 551,000, respectively.

As of March 31, 2026 and December 31, 2025, the Company had federal net operating loss carry forwards of $874,000 and $804,000, respectively, and state net operating loss carryforwards of $3,145,000 and $3,176,000, respectively, which may be used to offset future taxable income. The remaining federal NOL's will not expire but will be limited to 80% of taxable income. The Pennsylvania NOL's began to expire in 2024, with $1,307,000 expiring by 2032. The remaining Pennsylvania NOL's expire in 20 years and the Florida NOL's will not expire.

The tax effects of temporary differences which give rise to deferred tax assets (liabilities) are summarized as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Deferred tax assets/(liabilities) |  |  |
| Net operating loss carryforward | $424200 | $412600 |
| R&D Credits | 85900 | 80300 |
| Stock-based compensation | 2100 |  |
| Operating lease assets | 2000 | 2200 |
| Capitalize research & development costs | 48800 | 53600 |
| Depreciation & amortization | 2600 | 2300 |
| Total deferred tax assets | 565600 | 551000 |
| Valuation allowance | (565600) | (551000) |
| Net | $— | $— |

---

For the quarter ended March 31, 2026, the net increase in valuation allowance was $14,600.

Reconciliation of the statutory federal income tax to the Company's effective tax:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  | **Amount** | **%** | **Amount** | **%** |
| &nbsp;&nbsp;U.S. Federal statutory tax rate | (13100) | 21.00 | (32500) | 21.00 |
| &nbsp;&nbsp;State and local income tax, net of federal income tax effect |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania state modifications | (7100) | 11.40 | (33200) | 21.40 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania income tax | (4700) | 7.50 | (11800) | 7.63 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;State valuation adjustment | (4100) | 6.60 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania net operating loss expiration | 15800 | (25.30) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 100 | (0.10) | (2300) | 1.38 |
| &nbsp;&nbsp;Tax credits | (5600) | 8.90 | (39000) | 25.20 |
| &nbsp;&nbsp;Changes in valuation allowance | 18500 | (29.70) | (160400) | 103.59 |
| &nbsp;&nbsp;Nontaxable or nondeductible items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Return to provision adjustments |  |  | 19000 | (12.29) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expiration of net operating losses |  |  | 260000 | (167.91) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 200 | (0.30) |  |  |
| &nbsp;&nbsp;Provision for income taxes |  |  |  |  |

---

<br> **<u>NOCOPI TECHNOLOGIES, INC.</u>**<br>**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**<br>**(UNAUDITED)**<br>

Internal Revenue Code Section 382 limits the ability to utilize net operating losses if a 50% change in ownership occurs over a three-year period. Such limitation of the net operating losses may have occurred, but we have not analyzed it at this time as the deferred tax asset is fully reserved.

The Company's policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. The Company did not recognize any interest or penalties during 2026 related to unrecognized tax benefits.

Tax years ending December 31, 2022 and thereafter remain open to examination for federal income tax purposes and by other major taxing jurisdictions to which the Company is subject.

**Note 7. Earnings (Loss) per Share**

In accordance with FASB ASC 260, *Earnings per Share*, basic earnings (loss) per common share is computed using net earnings (loss) divided by the weighted average number of common shares outstanding for the periods presented. Diluted earnings (loss) per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. The potential common shares related to unvested RSUs were excluded from diluted EPS because their effect would be antidilutive.

**Note 8. Major Customer and Geographic Information**

The Company's revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of the Company's total revenues were:

---

| | | |
|:---|:---|:---|
|  | **Three Months ended**<br> **March 31** | **Three Months ended**<br> **March 31** |
|  | **2026** | **2025** |
| Customer A | 68% | 51% |
| Customer B | 17% | 12% |
| Customer C | 0% | 21% |

---

The Company's non-affiliate customers whose individual balances amounted to more than 10% of the Company's net accounts receivable, expressed as a percentage of net accounts receivable, were:

---

| | | |
|:---|:---|:---|
|  | **March 31<br> 2026** | **December 31<br> 2025** |
| Customer A | 15% | 0% |
| Customer B | 72% | 82% |

---

The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on the Company's business operations and financial condition.

The Company's revenues by geographic region are as follows:

---

| | | |
|:---|:---|:---|
|  | **Three Months ended**<br> **March 31** | **Three Months ended**<br> **March 31** |
|  | **2026** | **2025** |
| North America | $83100 | $185100 |
| South America | 800 |  |
| Asia | 284000 | 272200 |
| Australia | 21800 | 21700 |
|  | $389700 | $479000 |

---

<br> **<u>NOCOPI TECHNOLOGIES, INC.</u>**<br>**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**<br>**(UNAUDITED)**<br>

**Note 9. Leases** 

The Company conducts its operations in leased facilities under a non-cancelable operating lease expiring on December 31, 2027.

The Company entered into a second amendment to the operating lease agreement, effective June 1, 2025, relating to the leased facilities. The second amendment provides for an extension term to December 31, 2027, and for monthly rent payments of, initially, $7,147, escalating annually by 3.5%.

The Company has capitalized the present value of the minimum lease payments commencing June 1, 2025, using an estimated incremental borrowing rate of 6.5%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

As of March 31, 2026 and December 31, 2025, the operating lease asset amounted to $142,300 and $161,300, respectively, and operating lease liability amounted to $149,300 and $168,900, respectively.

There are no other material operating leases. The Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases. The Company's leases do not contain variable lease payments or residual value guarantees.

Total operating lease costs were $21,600 and $19,800 for the three months ended March 31, 2026 and 2025, respectively.

Undiscounted future minimum lease payments as of March 31, 2026, by year and in aggregate are as follows:

---

| | |
|:---|:---|
| | **Operating Leases** |
| **Year ending December 31** |  |
| 2026 | $66600 |
| 2027 | 91900 |
| Total lease payments | 158500 |
| Less imputed interest | (9200) |
| Total | $149300 |

---

**Note 10. Segment Reporting**

The Company operates as a single reportable segment, as the Chief Operating Decision Maker ("CODM"), the Chief Executive Officer ("CEO"), evaluates the business on a consolidated basis and does not receive discrete financial information for multiple business units.

**Measure of Segment Profit or Loss**

The CODM assesses the Company's financial performance based on operating loss, which aligns with the amount reported in the statement of comprehensive loss. The following table presents a reconciliation of segment operating loss to net (loss) income:

---

| | | |
|:---|:---|:---|
|  | **Three Months ended** <br> **March 31** | **Three Months ended** <br> **March 31** |
|  | **2026** | **2025** |
| **Revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Licenses, royalties and fees | $100700 | $190300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product and other sales | 289000 | 288700 |
| Total revenues | 389700 | 479000 |
| **Cost of revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Licenses, royalties and fees | 46400 | 43500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product and other sales | 152700 | 161800 |
| Total cost of revenues | 199100 | 205300 |
| **Gross profit** | 190600 | 273700 |
| **Operating expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 55800 | 45000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 74500 | 91000 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 221800 | 223500 |
| Total operating expenses | 352100 | 359500 |
| **Net loss from operations** | (161500) | (85800) |
| **Other income (expenses)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 105200 | 117200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and bank charges | (6000) | (5900) |
| Total other income | 99200 | 111300 |
| **Net (loss) income before income taxes** | (62300) | 25500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes |  |  |
| **Net (loss) income** | $(62300) | $25500) |

---

<br> **<u>NOCOPI TECHNOLOGIES, INC.</u>**<br>**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**<br>**(UNAUDITED)**<br>

**Significant Segment Expenses**

The Company considers the following as significant expenses in evaluating its segment performance:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Research and Development: includes costs related to personnel, laboratory materials and supplies and product development and testing for ink technologies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· General and Administrative: includes personnel costs, professional fees, and other overhead expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Sales and Marketing: includes personnel costs and other sales related expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Cost of Revenues: represents labor costs, material costs and manufacturing overhead costs associated with the production of materials transferred to the customer from the Company's facility.

Since the Company has only one reportable segment, no additional segment disclosures are required beyond entity-wide disclosures presented below.

**Entity-Wide Disclosures**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Geographic Revenue Information: For the three months ended March 31, 2026, 21 % of the Company's net sales were generated in North America and 79 % internationally. For the three months ended March 31, 2025, 39 % of the Company's net sales were generated in North America and 61 % were generated internationally. Refer to Note 8.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Major Customers: The Company had two customers that accounted for 85 % of revenue and 87 % of net accounts receivable for the three months ended March 31, 2026. In addition, the Company had three customers that accounted for 84 % of revenue for the three months ended March 31, 2025 and one customer that accounted for 82 % of net accounts receivable as of December 31, 2025. Refer to Note 8.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**Forward-Looking Information**

This Quarterly Report on Form 10-Q contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Expected operating results, such as revenue, expenses and capital expenditures

· Current or future volatility in market conditions

· Our belief that we have sufficient liquidity to fund our business operations during the next twelve months

· Strategy for customer retention, growth, product development, market position, and risk management

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.

· Strategic actions, including business acquisitions and our success in integrating acquired businesses.

· Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.

· The impact of losing our intellectual property protections or the loss in value of our intellectual property.

· Changes in customer demand.

· The occurrence of hostilities, political instability or catastrophic events.

· D evelopments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards.

· Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems.

· Such other factors as discussed throughout Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q, and throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and in Part I, Item 1A. Risk Factors of the 2025 Annual Report.

Any forward-looking statement made by us in this Quarterly Report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

The following discussion and analysis should be read in conjunction with our condensed financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management. This information should also be read in conjunction with our audited historical financial statements which are included in the Annual Report.

**Background Overview**

Nocopi Technologies, Inc. develops and markets specialty reactive inks for applications in the large educational and toy products market. We also develop and market technologies for document and product authentication, which we believe can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.

Unless the context otherwise requires, all references to the "Company," "we," "our" or "us" and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.

**Results of Operations**

The Company's revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee's sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.

The Company recognizes revenue on its lines of business as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;

b. Product sales are recognized at the time of the transfer of goods to customers at an amount that the Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and

c. Fees for technical services are recognized at the time of the transfer of services to customers at an amount that the Company expects to be entitled to in exchange for the services, which is when the service has been rendered.

We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.

Both the absolute amount of the Company's revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on the Company's total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer's product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when the Company agrees to revise such terms, revenues from the customer may be adversely affected.

Revenues for the first quarter of 2026 were $389,700 compared to $479,000 in the first quarter of 2025, a decrease of $89,300, or approximately 19%. Licenses, royalties and fees decreased by $89,600, or approximately 47%, in the first quarter of 2026 to $100,700 from $190,300 in the first quarter of 2025. The decrease in licenses, royalties and fees in the first quarter of 2026 compared to the first quarter of 2025 is due primarily to the renewal of one of our existing licenses in January 2025. We cannot assure you that the marketing and product development activities of the Company's licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for the Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions presently being experienced.

Product and other sales increased by $300, or approximately 0.1%, to $289,000 in the first quarter of 2026 from $288,700 in the first quarter of 2025. Sales of ink increased in the first quarter of 2026 compared to the first quarter of 2025 due primarily to higher ink shipments to the third party authorized printer used by two of the Company's major licensees in the entertainment and toy products market. In the first quarter of 2026, the Company derived revenues of approximately $375,700 from the Company's licensees and their authorized printers in the entertainment and toy products market compared to revenues of approximately $354,900 in the first quarter of 2025.

The Company's gross profit decreased to $190,600, or approximately 49% of gross revenues, in the first quarter of 2026 from $273,700, or approximately 57% of gross revenues, in the first quarter of 2025 due to decrease in licenses and royalties. Licenses, royalties and fees have historically carried a higher gross profit than product and other sales, which generally consist of either supplies or other manufactured products which incorporate the Company's technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by the Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees.

As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both the gross profit from these sources as well as the Company's overall gross profit. The gross profit from licenses, royalties and fees decreased to approximately 54% in the first quarter of 2026 from approximately 77% in the first quarter of 2025.

The gross profit of product and other sales, expressed as a percentage of revenues, is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. Primarily due to higher sales of ink and other products and the overall mix in the first quarter of 2026 compared to the first quarter of 2025, there was a higher gross profit from product and other sales of approximately 47% of revenues in the first quarter of 2026 compared to a gross profit of approximately 44% of revenues in the first quarter of 2025.

Research and development expenses increased in the first quarter of 2026 to $55,800 compared to $45,000 in the first quarter of 2025 due primarily to higher lab expenses in the first quarter of 2026 compared to the first quarter of 2025.

Sales and marketing expenses decreased to $74,500 in the first quarter of 2026 from $91,000 in the first quarter of 2025 due primarily to lower commission expense on the lower level of revenues in the first quarter of 2026 compared to the first quarter of 2025.

General and administrative expenses decreased in the first quarter of 2026 to $221,800 compared to $223,500 in the first quarter of 2025 due primarily to higher stock-based compensation, lower professional fees, and higher employee related expenses in the first quarter of 2026 compared to the first quarter of 2025.

For the first quarter of 2026 and 2025, there was no income tax benefit for the net (loss) income for the first quarter of 2026 and 2025 due to the recording of a full valuation allowance since it is more likely than not that that the realization of the net deferred tax assets would not be realized. Income taxes in the first quarter of 2025 include federal and state income taxes. The state income taxes result from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.

The net loss of $62,300 in the first quarter of 2026 compared to the net income of $25,500 in the first quarter of 2025 resulted primarily from a lower level of licenses, royalties and fees in combination with lower quarterly operating expenses, as well as the positive other income generated in the first quarter of 2026, when compared to the first quarter of 2025.

**Plan of Operation, Liquidity and Capital Resources**

During the first quarter of 2026, the Company's cash increased to $11,913,000 at March 31, 2026 from $11,553,600 at December 31, 2025. During the first quarter of 2026, the Company used $27,000 and $13,600 from its operating activities and investing activities, respectively, and generated $400,000 from financing activities. During the first quarter of 2025, the Company's cash increased to $11,209,400 at March 31, 2025 from $10,839,700 at December 31, 2024. During the first quarter of 2025, the Company generated $369,700 from its operating activities.

During the first quarter of 2026, the Company's revenues decreased approximately 19% primarily as a result of lower licenses, royalties and fees revenue in the entertainment and toy products market. Our total overhead expenses decreased in the first quarter of 2026 to $352,100 compared to $359,500 in the first quarter of 2025, and the Company's interest income decreased in the first quarter of 2026 compared to the first quarter of 2025. As a result of these factors, the Company had a net loss of $62,300 in the first quarter of 2026 compared to net income of $25,500 in the first quarter of 2025. The Company had negative operating cash flow of $27,000 during the first quarter of 2026. At March 31, 2026, the Company had working capital of $13,257,700 and stockholders' equity of $13,949,000. For the three months ended March 31, 2026, the Company had a net loss of $62,300 and had negative operating cash flow of $27,000. At March 31, 2025, the Company had working capital of $12,526,100 and stockholders' equity of $13,667,300.

Our plan of operation for the twelve months beginning with the date of this Quarterly Report on Form 10-Q consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships the Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating the Company's technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with the Company. We will continue to develop various applications for these licensees. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.

The Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable the Company to generate additional revenues and positive cash flow.

Our future growth strategy includes expanding our business through acquisitions of other companies with competing or complementary services, technologies or businesses in order to expand our product and service offerings to grow our free cash flow. We are currently actively engaged in the process to identify acquisition candidates and negotiate transactions. As of the date of this Quarterly Report on Form 10-Q, we have not entered into any definitive agreements to make any acquisition. We expect to fund our business expansion through the issuance of debt or equity securities, the payment of cash, the exchange of services, or any combination thereof.

The Company has received, and may in the future seek, additional capital in the form of debt, equity or both, to support our working capital requirements and to provide funding for other business opportunities. We cannot assure you that if we require additional capital, that we will be successful in obtaining such additional capital, or that such additional capital, if obtained, will enable the Company to generate additional revenues and positive cash flow.

As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment in 2026 and beyond and its effect on the global economy, geopolitical instability including the Russia-Ukraine war and conflicts in the Middle East and the related supply chain disruptions as well as the record inflation and significantly higher interest rates currently being experienced in the United States along with the probability of an economic recession both in the United States and globally. As a result, our revenues, results of operations and liquidity may be negatively impacted in future periods.

**Contractual Obligations**

As of March 31, 2026, there were no material changes in our contractual obligations from those disclosed in the 2025 Annual Report, other than those appearing in the notes to the financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.

**Recently Adopted Accounting Pronouncements**

As of March 31, 2026 and for the period then ended, there are no recently adopted accounting standards that have a material effect on the Company's financial statements.

**Recently Issued Accounting Pronouncements Not Yet Adopted**

As of March 31, 2026, there were no recently issued accounting standards not yet adopted that would have a material effect on the Company's financial statements.

**Off-Balance Sheet Arrangements**

The Company does not have any off-balance sheet arrangements.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

Not Applicable

**Item 4. Controls and Procedures.**

*Evaluation of Disclosure Controls and Procedures.* The Company's management, with the participation of the Company's Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of March 31, 2026. Based on this evaluation, the Company's Principal Executive Officer and Principal Financial Officer concluded that, as of March 31, 2026, the Company's disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and is accumulated and communicated to the Company's management, including the Company's Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Management's evaluation considered the Company's size and staffing levels, including management review controls implemented during 2025 and continuing through the quarter ended March 31, 2026

*Changes in Internal Control Over Financial Reporting.* There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings.**

None

**Item 1A. Risk Factors.**

Information about risk factors for the quarter ended March 31, 2026 does not differ materially from that set forth in Part I, Item 1A of the 2025 Annual Report.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

On December 31, 2025, the Company entered into Stock Purchase Agreements (the "Purchase Agreements"), by and between the Company and various institutional investors (the "Purchasers").The Purchase Agreements provided for the private issuance (the "Private Placement") to the Purchasers of an aggregate of 266,666 shares of the Company's common stock (such shares of common stock issued pursuant to the Private Placement, the "Placement Shares") at a purchase price of $1.50 per share. On January 9, 2026, the Private Placement closed and the Company received aggregate gross proceeds of $400,000, which will be used for future acquisitions.

Kevin Westenburg, the Company's President and a Director, purchased 33,333 Placement Shares in connection with the Private Placement.

Third Parties purchased an aggregate of 233,333 Placement Shares in connection with the Private Placement.

In connection with the Purchase Agreements, on December 31, 2025, the Company entered into registration rights agreements with certain of the Purchasers, which provides that on or prior to January 9, 2027, the Company must file a registration statement to register the Purchaser's respective Placement Shares.

**Item 3. Defaults Upon Senior Securities.**

None

**Item 4. Mine Safety Disclosures.**

Not applicable

**Item 5.** **Other Information.**

From time to time, certain of our executive officers and directors have, and we expect they will in the future, enter into, amend or terminate written trading arrangements pursuant to Rule 10b5-1 of the Securities and Exchange Act or otherwise.

For the quarter ended March 31, 2026, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and/or any "non-Rule 10b5-1 trading arrangement," as defined in Item 408 of Regulation S-K.

**Item 6.** **Exhibits.**

(a) Exhibits

The following exhibits are included herein:

---

| | | |
|:---|:---|:---|
| **Exhibit Number** | **Description** | **Location** |
| 31.1 | [Certification of Chief Executive Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31x1.htm) | Filed herewith |
| 31.2 | [Certification of Chief Financial Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31x2.htm) | Filed herewith |
| 32.1 | [Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32x1.htm) | Furnished herewith |
| 101.INS | Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document | Filed herewith |
| 101.SCH | Inline XBRL Taxonomy Extension Schema | Filed herewith |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | Filed herewith |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | Filed herewith |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | Filed herewith |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | Filed herewith |
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | Filed herewith |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | **NOCOPI TECHNOLOGIES, INC.** |
| DATE: May 15, 2026 | /s/ Matthew C. Winger |
|  | Matthew C. Winger |
|  | Chairman of the Board & Chief Executive Officer (Principal Executive Officer) |
| DATE: May 15, 2026 | /s/ Debra E. Glickman |
|  | Debra E. Glickman |
|  | Chief Financial Officer (Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

I, Matthew C. Winger, Chief Executive Officer of Nocopi Technologies, Inc., certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Nocopi Technologies, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

DATE: May 15, 2026

<u>/s/ Matthew C. Winger</u>

Matthew C. Winger

Chief Executive Officer

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

I, Debra E. Glickman, Chief Financial Officer of Nocopi Technologies, Inc., certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Nocopi Technologies, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (registrant's fourth fiscal quarter in the case of annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

DATE: May 15, 2026

<u>/s/ Debra E. Glickman</u>

Debra E. Glickman

Chief Financial Officer

## Exhibit 32.1

**Exhibit 32.1**

CERTIFICATION PURSUANT TO<br> 18 U.S.C. SECTION 1350,<br> AS ADOPTED PURSUANT TO<br> SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Nocopi Technologies, Inc. (the "Company") on Form 10-Q for the Quarter ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Matthew C. Winger, Chief Executive Officer, and Debra E. Glickman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

DATE: May 15, 2026

<u>/s/ Matthew C. Winger</u>

Matthew C. Winger

Chief Executive Officer (Principal Executive Officer)

<u>/s/ Debra E. Glickman</u>

Debra E. Glickman

Chief Financial Officer (Principal Financial Officer)